A novel, fast, low-cost and scalable methodology to prepare stable magnetoliposomes (MGLs), without the use of organic solvents, is described. The concept of the work is based on the dual use of soy lecithin associated to a new liposome preparation methodology. Soy lecithin was used to coat the nanoparticles of magnetite ( 
Introduction
The disordered use of antibiotics has increased the inefficiency of several classes of antibacterial agents in combating microorganisms called multiresistant. Such microorganisms are present in hospitals of large metropolises or even diverse environments of small communities. [1] [2] [3] [4] [5] The Gram-positive bacterium Staphylococcus aureus is the leading cause of human bacterial infections worldwide, being endemic and readily resistant to antimicrobials. S. aureus is listed in the World Health Organization (WHO) 6 as one of the six pathogens with priority II (high) in the development of new antibiotics. Regarding Gram-negative bacteria, the WHO warns of resistance to multiple antibiotics and the ability to transmit genetic material to other bacteria. An example of Gramnegative bacteria, Citrobacter freundii is a fecal coliform that resides in water, soils, and intestines of humans. 7 Inorganic pharmaceuticals containing metal oxides may utilize different action mechanisms and can, therefore, be considered a viable alternative to traditional antibiotics. 8 One option is the use of iron oxide magnetic nanoparticles (IOMNPs). IOMNPs have been extensively explored in several areas, such as nanocatalysis, 9 hyperthermia, 10 magnetic resonance imaging 11 and cancer treatment. 12 The properties of IOMNPs are suitable for a wide diversity of applications, such as high surface area and heat generation capacity by the application of an external magnetic field. [9] [10] [11] [12] [13] Several studies on the antibacterial activity of IOMNPs, in particular the magnetite nanoparticles (NPs) are described in the literature. [14] [15] [16] [17] Limitations due to agglomeration and interactions with biological media have been overcome by coating the NPs with several classes of stabilizing agents. [18] [19] [20] [21] Another strategy to increase the interaction of NPs with biological media is encapsulation in liposomes, preparing so-called magnetoliposomes (MGLs). The encapsulation in liposomal vesicles permits reduced contact between drugs and healthy cells; as well as increased efficiency in traversing the diseased cell membrane to reach the target. 18, 22 In this paper, soy lecithin, a combination of phospholipids from renewable sources, was used to coat NPs (Fe 3 O 4 @lecithin) and then as liposome for encapsulating the Fe 3 O 4 @lecithin. Two previous studies 23, 24 using soy lecithin as the coat of NPs have been described. However, none of the studies used lecithin as a liposome. The addition of the second step for encapsulation of Fe 3 O 4 @lecithin was determinant to obtain more stable MGLs than Fe 3 O 4 @lecithin in the aqueous medium. Another factor that distinguishes our paper from the previous publications is the order of addition of reagents. In our work, soy lecithin was added after the co-precipitation, reducing the possibility of encapsulation residuals of initial reagents in the soy lecithin clusters. Therefore, dual use of the soy lecithin biomimetic agent 25 increased the interaction between Fe 3 O 4 and liposome vesicles in the Lip-Fe 3 O 4 @lecithin, creating new possibilities for the preparation of MGLs. Another enhancement was enabling the MGLs to be highly water-dispersive using a novel methodology that is fast, low-cost and scalable without the use of organic solvents, which were not previously described in the literature. Traditional methodologies such as film hydration 26 and sonication 27 require a lot of preparing time and the use of organic solvents to achieve small quantities of product. 28 Subsequently, they are still subjected to a sterilization step. 29 Therefore, a new methodology was proposed to prepare sterile liposomes. This methodology involves hydrating the soy lecithin in an autoclave at 120 °C for 15 min, cooling to 4 °C, liposome size reduction, encapsulating stigmasterol and/or Fe 3 O 4 @lecithin and using ultrasound tip. The use of an initial autoclave stage allows preparation of large amounts of the liposomes. The production is only limited by to the capacity of the autoclave equipment that can reach industrial scales. In addition, the influence of use of stigmasterol (Stigma), a molecule similar to cholesterol, was also investigated. 28, 29 The liposomes prepared were tested against S. aureus and C. freundii microorganisms in the presence of a magnetic field (MF41) of 200 Oe, 315 kHz and also in its absence at room temperature (WMF25) and at temperature of 41 °C (WMF41).
Experimental

Materials
Stigmasterol (Sigma-Aldrich Chemical Company, USA), soy lecithin (CRQ, Brazil), iron sulfate II ammoniacal hexahydrate (Vetec, Brazil), iron chloride III hexahydrate (Vetec, Brazil), CDCl 3 (Sigma-Aldrich Chemical Company, USA), ammonium hydroxide PA (Synth, Brazil), sodium hydroxide PA (Synth, Brazil), citric acid (Synth, Brazil), brain heart infusion (BHI) agar (Kasvi, Brazil), BHI broth (Kasvi, Brazil) were used without any purification. The Gram-positive and Gram-negative bacteria used were Staphylococcus aureus (ATCC 29212), and Citrobacter freundii (ATCC 8090), respectively. The ultrapurified water was obtained by Milli-Q system (Millipore, Brazil).
Preparation of the bare liposome (Lip)
Bare liposomes were prepared by hydration of soy lecithin (100 mg mL -1 ) in ultra-purified water. The autoclavable flask containing the components were autoclaved (CS Prismatec Autoclave, Brazil) for 15 min at 120 °C. Bare liposomes were maintained at 4 °C for 24 h. Then, the bare liposomes were sonicated on tip ultrasound (Disruptor Unique Model DES 500, Brazil) for reducing sizes. 26, 30 Standards of 4 cycles × 4 min were performed with intervals of 1 min for each sequence, at 95% power (500 W). The temperature of sample was maintained below 75 °C. The sample was noted Lip.
Synthesis of Fe 3 O 4 @lecithin
Magnetite coated with soy lecithin (Fe 3 O 4 @lecithin) was prepared in a one-pot reaction using the modified co-precipitation methodology of the literature. 31, 32 Briefly, in a two-neck round bottom flask, under nitrogen flow, 500 mL of ultra-purified and degassed water were mixed to Fe(NH 4 (Table 1) determined by atomic absorption spectroscopy (AAS) and proton nuclear magnetic resonance ( The FTIR spectra were recorded in transmittance mode in the 4000 to 400 cm -1 range. Morphologies, particle size distribution, and phases by micrographs were recorded on transmission electron microscope Tecnai G2-20 SuperTwin FEI, 200 kV (USA). The samples were diluted in water and one drop was deposited on holey carbon-Cu, 300 mesh, 50 micron screens. 37 The micrographs were obtained in the conventional and high-resolution transmission electron microscopy (TEM/HRTEM) and energy-filtered transmission electron microscopy (EFTEM) modes. Biological activity without magnetic field at room temperature (WMF25), without magnetic field at 41 ± 1 °C (WMF41) and with magnetic field at 41 ± 1 °C (MF41) Antibacterial activity of the liposomes was assayed by the agar dilution method. 39 Bacteria S. aureus (ATCC 29213) and C. freundii (ATCC 8090) were individually inoculated in vials containing BHI broth and incubated in an oven at 37 °C for 24 h. Inoculum containing approximately 1 × 10 6 colony forming units (CFU) of each microorganism per mL of sterile water were prepared in sterile vials (InocSol). Liposomes samples described in Table 1 and InocSol were added to Eppendorfs containing BHI broth. The final concentrations of liposomes were presented in the Table 2 with total volume of the 1 mL per Eppendorf.
Tests for S. aureus and C. freundii inhibition were done against the liposomes samples prepared under three different conditions: (i) 25 °C for 30 min (WMF25); (ii) oven heating at 41 ± 1 °C for 30 min (WMF41); and (iii) magnetic field for 30 min at 41 ± 1 °C (MF41). The sample with number 2 was tested against S. aureus and C. freundii in the condition: (iii) magnetic field for 30 min at 41 ± 1 °C (MF41). The liposome samples were diluted in BHI agar plates and maintained at 37 °C for 24 h. Then the CFUs were quantified. The procedure was performed in triplicate. Quantification of inhibition of bacterial growth was done according to the literature. 39, 40 Samples submitted to MF41 treatment were accompanied by a reference sample (no inoculum) of the same concentration and volume for temperature control. Samples (1 mL) were placed in the center of the three-turn coil with internal diameter of 3.2 cm and a magnetic field of 200 Oe, 300 A and frequency of 315 kHz (Easyheat Ambrell, models 0224, USA) was applied for 30 min. When the temperature reached about 41.8 °C, the equipment was switched off and restarted only when the temperature was below 40.5 °C. The total time of 30 min in the magnetic field did not consider the time required for the sample to be cooled so that the temperature did not reach values higher than 42 °C. The samples were kept inside the coil throughout the treatment. The temperature variation in the reference sample was measured through a fiber optic thermometer (New Star 5kW RF Power Supply, Ameritherm, Inc., USA) located in the center of the Eppendorf (reference sample). The heat rate measurements were recorded by a Photon Control software TPMeter 10FTC-DIN-GT-HT.
Results and Discussion
The first step in preparing the MGLs involved the synthesis of magnetite through a modified co-precipitation method previously described 31, 32 and then the modification of its surface in a one-pot reaction is shown in Figure 1 (steps 1a, 1b and 2) to prepare Fe 3 O 4 @lecithin.
Characterization of Fe 3 O 4 @lecithin
The TEM image (Figure S1a (Figure 2 ) was determined by X-ray powder diffraction (XRPD) according to JCPDS card 19-629. The mean diameter of 15 nm of the crystallite was determined by the Debye-Scherer equation. 41, 42 The structure determined was of cubic face centered (fcc) Fd-3m without deformation. The calculated net parameter was a = 8.41 Å and the density was 5.18 g cm SI section) . 43 The average magnetic core diameter calculated using the Fortran 90 software program was 12.7 ± 0.2 nm confirming the values determined by TEM and XRPD. This value is consistent with nanoparticle super paramagnetic behavior. 40 The zeta potential (ζ) values found for Fe 3 O 4 @lecithin were -19 ± 1 mV. The zeta potential (ζ) confirms the stability of NPs with high water-dispersion in an aqueous medium.
The second step in MGLs preparation involves the encapsulation of the stigmasterol (Lip-Stigma), of F e 3 O 4 @ l e c i t h i n ( L i p -F e 3 O 4 @ l e c i t h i n ) a n d encapsulation of the stigmasterol and Fe 3 O 4 @lecithin (Lip-Stigma-Fe 3 O 4 @lecithin) as shown in Figure 1 (step 3) . The samples were compared to the bare liposome (Lip).
Characterization of liposomes
The liposome size, polydispersity index (PI), zeta potential (ζ), pH and the FTIR of the liposomes (Table 1) were evaluated for 14 days (Table 3) . Liposomes exhibited temporal stability in aqueous medium and PI compatible with pharmaceutical applications. The zeta potential of the liposomes shows high values without the tendency toward agglomeration corroborating with the observed stability. 44, 45 The pH of the liposome samples remained stable at pH 7.3 ± 0.1. Figures 5a and 5b show the overlap of lecithin spectra with Lip-Stigma (Figure 5a ) and lecithin with stigmasterol ( Figure 5b ). The overlap of the FTIR spectrum of lecithin and Lip-Stigma (Figure 5a ) shows characteristic bands of soy lecithin components: 1741 cm -1 (ester carbonyl); 1261 and 1044 cm -1 (P-O-R bonds); 1630 cm -1 (-C=C-, linoleic acid). It was possible to observe that there were no changes in the spectra pattern due to autoclaving and ultrasound of the sample in the Lip-Stigma. The absence of new bands in the 1600-1800 cm -1 in relation to soy lecithin corroborates with the observation of absence of free fatty acids, due to the process of the autoclaving and sonication in the Lip and Lip-Stigma. [46] [47] [48] Comparison of the soy lecithin sample with the stigmasterol pattern (Figure 5b ) shows an overlap of the stigmasterol bands with the soy lecithin bands. This can be explained by the presence of steroids in the initial lecithin sample hindering the detection of stigmasterol. The band at 570 cm -1 (Figures 5c and 5d ) confirms the presence of the Fe-O bond of the magnetite phase showing that the NPs coating coverage was efficient in maintaining the magnetite as the only phase. [49] [50] [51] [52] [53] The comparison of Lip-Fe 3 O 4 @lecithin and Fe 3 O 4 @lecithin spectra (Figure 3 ) reveals the intensification of the bands pertaining to lecithin due to the encapsulation of Fe 3 O 4 @lecithin.
The TEM image and EFTEM maps 54 of C coated (of soy lecithin) (Figures 6a and 6b) Table 4 . The values found are in agreement with the XRPD technique (Figure 2) . However, in the XRPD spectra of Lip-Fe 3 O 4 @lecithin and Lip-Stigma-Fe 3 O 4 @lecithin, one can observe lower intensity of magnetite peaks due to the presence of soybean lecithin (amorphous) and it is also possible to observe peaks attributed to stigmasterol (JCPDS 10-638). The HRTEM technique enabled nanoscale analysis and the reduction of interferences observed in the XRPD spectrum due to the increase in the amount of soy lecithin and stigmasterol. Therefore 53 The liposome size, zeta potential (ζ), pH and characterization by FTIR, HRTEM, EFTEM/electron energy loss spectroscopy (EELS) and magnetics measurements show promising stability for suitable pharmaceutical. 55 The use of soy lecithin as the encapsulating agent offers advantages of commercial availability, low-cost, high encapsulation capacity, high zeta potential and physicochemical stability. The usual components described in the literature are phospholipids (PL) and steroids (S). 56, 57 The 1 H NMR was used for the determination of molar ratio The inhibition of microbial growth at 24 h was shown in Figure 8 . The strains S. aureus and C. freundii were sensitive to the liposomal formulations studied under all conditions. The WMF41 condition was established to evaluate the effect of temperature without the presence of a magnetic field in the antibacterial activity. Comparing the three conditions: WMF25, WMF41 and MF41, it can be seen that the elevation of temperature without the presence of the magnetic field increased bacterial growth. This occurrence was also observed in the study of Pseudomonas biofilms by Park et al. 58 Kim et al. 59 also observed increased antibacterial activity due to the presence of the magnetic field in the study with S. aureus. The most efficient condition for inhibiting growth of the microorganisms was MF41, achieving inhibitions of up to 98% of the S. aureus colonies for the Lip-Fe 3 O 4 @lecithin1. The specific absorption rate (SAR) calculated for samples Lip-Stigma-Fe 3 O 4 @lecithin1 and Lip-Fe 3 O 4 @lecithin1 were 1056 and 978 W g -1 of iron, respectively. 60 The presence of stigmasterol increased the encapsulation capacity of NPs of the liposomes and the response of the NPs to the magnetic field ( Figure S3 , SI section). All samples presented excellent temperature responses in the presence of magnetic field ( Figure S3 , SI section). 53, 59, 61 The limitation of temperature to 41 ± 1 °C was used based upon literature references to avoid damage to healthy human cells. 62 The evaluation of LipStigma1 in the MF41 condition shows that the stigma was active as antibacterial with inhibition of 92% of colonies. Traditional liposomes are accompanied by cholesterol as a steroid responsible for the control of drug release. 28, 29 We decided to use stigmasterol because it is an abundant vegetable steroid which are proven to have biological activities. and results. 14, 16, 19, 20, 65, 66 In our work, the broth microdilution method using UV 67 was initially tested, however, the results were not reproducible. Alternatively, the use of the agar dilution method 39 proved to be more reliable and reproducible. A prior evaluation of the literature data shows that the nature of the coating was determinant in the activity's result. In the literature consulted, the best result described without a magnetic field was 47 μg mL -1 . 16 When compared to our work, we observed that the encapsulating of Fe 3 O 4 @lecithin into liposomes and the application of a magnetic field reduced the dosage required for MIC by approximately 6-fold.
Conclusions
In summary, this work resulted in an enhanced methodology for preparation of magnetoliposomes in terms of time, scalability and cost. Contrary to the liposomes conventional preparation, which uses toxic organic solvents, the methodology applied in this work does not use organic solvents. Additionally, the new process led to low risk of microbial contamination due to sterilization effect resulting from the autoclave step, inherent to the methodology. Liposomes prepared with soy lecithin show stability of physicochemical properties (liposome size, temporal stability, polydispersity index, zeta potential) and excellent magnetic response in vitro (SAR of 1056 W g -1 ) allowing a wide range of biomedical applications for treatments of multi-resistant microorganisms in the presence of magnetic field.
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